IGM Biosciences, Inc.: net income or loss

What this measure means

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Exact concept: us-gaap:NetIncomeLoss. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2017-01-01 to 2024-12-31. The SEC response was captured on 2026-09-21.

Selected filing history

Related financial histories

• IGM Biosciences, Inc.: total assets
• IGM Biosciences, Inc.: total liabilities
• IGM Biosciences, Inc.: stockholders equity
• IGM Biosciences, Inc.: cash and cash equivalents
• IGM Biosciences, Inc.: operating cash flow
• IGM Biosciences, Inc.: capital expenditure payments
• IGM Biosciences, Inc.: financing cash flow
• IGM Biosciences, Inc.: investing cash flow
• IGM Biosciences, Inc.: retained earnings or deficit
• IGM Biosciences, Inc.: basic weighted-average shares
• IGM Biosciences, Inc.: diluted weighted-average shares
• IGM Biosciences, Inc.: basic earnings per share
• IGM Biosciences, Inc.: diluted earnings per share
• IGM Biosciences, Inc.: income tax expense or benefit
• IGM Biosciences, Inc.: net property, plant and equipment
• IGM Biosciences, Inc.: share-based compensation expense
• IGM Biosciences, Inc.: operating income or loss
• IGM Biosciences, Inc.: current assets
• IGM Biosciences, Inc.: current liabilities
• IGM Biosciences, Inc.: current accounts payable
• IGM Biosciences, Inc.: operating expenses
• IGM Biosciences, Inc.: research and development expense
• IGM Biosciences, Inc.: common shares outstanding
• IGM Biosciences, Inc.: cash including restricted cash
• IGM Biosciences, Inc.: accumulated other comprehensive income or loss
• IGM Biosciences, Inc.: operating lease right-of-use asset
• IGM Biosciences, Inc.: operating lease liability
• IGM Biosciences, Inc.: gross property, plant and equipment
• IGM Biosciences, Inc.: accumulated depreciation on property, plant and equipment
• IGM Biosciences, Inc.: other noncurrent assets
• IGM Biosciences, Inc.: accrued current liabilities
• IGM Biosciences, Inc.: prepaid expenses and other current assets
• IGM Biosciences, Inc.: pre-tax income or loss from continuing operations
• IGM Biosciences, Inc.: profit or loss including noncontrolling interests
• IGM Biosciences, Inc.: comprehensive income or loss
• IGM Biosciences, Inc.: general and administrative expense
• IGM Biosciences, Inc.: depreciation expense
• IGM Biosciences, Inc.: other nonoperating income or expense
• IGM Biosciences, Inc.: nonoperating income or expense
• IGM Biosciences, Inc.: income taxes paid, net
• IGM Biosciences, Inc.: proceeds from issuing common stock
• IGM Biosciences, Inc.: operating lease payments
• IGM Biosciences, Inc.: change in accounts payable

Inspect the source

Entity

IGM Biosciences, Inc. / CIK 0001496323

Captured

2026-09-21T17:20:24.248Z

SEC response SHA-256

44476d0a537cdd7f08202a0764ccea09f3a04b3a1d793913d853196f7383553c

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001496323.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))